Isofol Medical AB (publ)

Over the past 90 days, Isofol Medical AB (publ) recorded one insider transaction, consisting of a purchase valued at 92,300 SEK. This activity was conducted by CEO Petter Segelman Lindqvist. Historical data shows a pattern of both buying and selling activity by key executives, including the CEO and CFO, over the preceding year.
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Buy 15 Jun 2026
Value SEK966,918.99 | Price 426.27 | Shares 56,158
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-06-15 2026-06-15 B Purchase

Chief Executive Officer (CEO)/Managing Directory

Officer
56,158
426.27
SEK966,919
56,158 426.27 SEK966,919
2026-03-31 2026-03-30 B Purchase

Chief Executive Officer (CEO)/Managing Directory

Officer
94,551
317.87
SEK1,230,971
94,551 317.87 SEK1,230,971
2025-07-03 2025-07-03 B Purchase

Other member of the company's administrative, management or supervisory body

16,436
157.86
SEK886,478
16,436 157.86 SEK886,478
2025-07-03 2025-07-02 B Purchase

Chief Financial Officer (CFO)

Officer
7,222
9.60
SEK69,331
7,222 9.60 SEK69,331
2025-07-03 2025-07-02 B Purchase

Chief Executive Officer (CEO)/Managing Directory

Officer
2,412
9.60
SEK23,155
2,412 9.60 SEK23,155
2025-07-03 2025-07-02 B Purchase

Chief Executive Officer (CEO)/Managing Directory

Officer
40,449
9.60
SEK388,310
40,449 9.60 SEK388,310
2025-06-29 2025-06-27 B Purchase

Chief Financial Officer (CFO)

Officer
90,000
0.04
SEK3,600
90,000 0.04 SEK3,600
2025-06-24 2025-06-23 S Sale

Chief Executive Officer (CEO)/Managing Directory

Officer
400,000
0.09
SEK36,000
400,000 0.09 SEK36,000
2025-06-24 2025-06-19 B Purchase

Chief Executive Officer (CEO)/Managing Directory

Officer
1,139,601
0.09
SEK102,564
1,139,601 0.09 SEK102,564
2025-06-24 2025-06-19 S Sale

Chief Executive Officer (CEO)/Managing Directory

Officer
33,408
0.09
SEK3,007
33,408 0.09 SEK3,007
2024-09-23 2024-09-23 B Purchase

Chief Financial Officer (CFO)

Officer
40,000
2.56
SEK102,400
40,000 2.56 SEK102,400
2024-09-16 2024-09-13 S Sale

Chief Financial Officer (CFO)

Officer
35,500
2.57
SEK91,235
35,500 2.57 SEK91,235
2024-08-21 2024-08-21 B Purchase

Chief Executive Officer (CEO)/Managing Directory

Officer
7,777
2.69
SEK20,956
7,777 2.69 SEK20,956
2024-07-12 2024-07-12 B Purchase

Chief Executive Officer (CEO)/Managing Directory

Officer
7,777
2.47
SEK19,170
7,777 2.47 SEK19,170
2024-07-05 2024-07-05 B Purchase

Chief Executive Officer (CEO)/Managing Directory

Officer
7,777
0.94
SEK7,287
7,777 0.94 SEK7,287
2024-03-27 2024-03-26 B Purchase

Chief Executive Officer (CEO)/Managing Directory

Officer
6,348
0.80
SEK5,091
6,348 0.80 SEK5,091
2024-01-11 2024-01-11 B Purchase

Chief Financial Officer (CFO)

Officer
35,000
0.69
SEK24,150
35,000 0.69 SEK24,150
2022-09-12 2022-09-12 B Purchase

Chief Executive Officer (CEO)/Managing Directory

Officer
500,000
0.61
SEK305,000
500,000 0.61 SEK305,000
2021-06-14 2021-06-14 B Purchase

Chief Executive Officer (CEO)/Managing Directory

Officer
233,336
6.40
SEK1,493,350
233,336 6.40 SEK1,493,350
2021-06-14 2021-06-11 S Sale

Chairman of the Board of Directors

Director
2
0.00
SEK0
2 0.00 SEK0
Explore more

More insider trading research around Isofol Medical AB (publ)